Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study

Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study

<i>Background</i>: Lung cancer is the most common cause of cancer-related deaths worldwide. Early diagnosis is crucial to increase the curability chance of the patients. Low dose CT screening can reduce lung cancer mortality, but it is associated with several limitations. Metabolomics is...

Full description

Bibliographic Details
Main Authors: Sandeep Singhal, Christian Rolfo, Andrew W. Maksymiuk, Paramjit S. Tappia, Daniel S. Sitar, Alessandro Russo, Parveen S. Akhtar, Nazrina Khatun, Parveen Rahnuma, Ahmed Rashiduzzaman, Rashid Ahmed Bux, Guoyu Huang, Bram Ramjiawan
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Cancers
Subjects:
metabolomics
lung cancer
metabolomic fingerprint
NSCLC
polyamine
SSAT-1
Online Access:https://www.mdpi.com/2072-6694/11/8/1069

Internet

https://www.mdpi.com/2072-6694/11/8/1069

Similar Items